Updates in Esophagogastric Cancer
David H. Ilson, MD, PhD, Editor Taken together, esophageal and gastric cancers are the second leading cause of cancer mortality globally, with a particularly high toll in countries of East…
Gastric and Esophageal Cancer 2017
Nicholas J. Petrelli, MD, FACS, Consulting Editor This issue of the Surgical Oncology Clinics of North America discusses esophageal and gastric cancer. The guest editor is David H. Ilson, MD,…
Advances in Esophageal and Gastric Cancer
SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA www.surgonc.theclinics.com Consulting Editor NICHOLAS J. PETRELLI April 2017 • Volume 26 • Number 2 Related posts: Gastric and Esophageal Cancer 2017 Updates in Esophagogastric…
Novel Opportunities to Use Radiation Therapy with Immune Checkpoint Inhibitors for Melanoma Management
Immunotherapy has revolutionized the systemic management of numerous malignancies. Nowhere has the proven benefit of these agents in clinical practice been more evident than in the management of advanced melanoma….
Brachytherapy in the Management of Prostate Cancer
Brachytherapy is performed by directly inserting radioactive sources into the prostate gland and is an important treatment option for appropriately selected men with prostate adenocarcinoma. Brachytherapy provides highly conformal radiotherapy…
Radiation Oncology Management of Stage I–III Cervix Cancer
Radiotherapy plays a critical role in the management of cervix carcinoma, in the adjuvant setting for patients with high-risk pathologic features and in the definitive setting for locoregionally advanced disease….
Evolving Role of Radiotherapy in the Management of Rectal Carcinoma
Management of locally advanced rectal cancer has evolved over time from surgical resection alone to multimodality therapy with preoperative radiation, chemotherapy, and total mesorectal excision resulting in excellent local control…
The Role of Radiation Therapy for Pancreatic Cancer in the Adjuvant and Neoadjuvant Settings
Pancreatic cancer is the third leading cause of cancer-related death in the United States. Although surgery remains the only curative treatment, chemotherapy and radiation therapy are frequently used. In the…
Optimal Use of Combined Modality Therapy in the Treatment of Esophageal Cancer
Esophageal cancer is associated with a poor prognosis with 5-year survival rates of approximately 15% to 20%. Although patients with early stage disease may adequately be treated with a single…
Management of Stage I Lung Cancer with Stereotactic Ablative Radiation Therapy
Early stage non–small cell lung cancer is a growing clinical entity with evolving standards of care. With the adoption of lung screening guidelines, the incidence of early stage disease is…
